182 related articles for article (PubMed ID: 16237980)
1. [Brain metabolism alterations in patients with anorexia nervosa observed in 1H-MRS].
Grzelak P; Gajewicz W; Wyszogrodzka-Kucharska A; Rotkiewicz A; Stefańczyk L; Góraj B; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(4):761-71. PubMed ID: 16237980
[TBL] [Abstract][Full Text] [Related]
2. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
Castro-Fornieles J; Bargalló N; Lázaro L; Andrés S; Falcon C; Plana MT; Junqué C
J Psychiatr Res; 2007 Dec; 41(11):952-8. PubMed ID: 17112540
[TBL] [Abstract][Full Text] [Related]
3. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
4. [1H-MR spectroscopy in anorexia nervosa: reversible cerebral metabolic changes].
Möckel R; Schlemmer HP; Gückel F; Göpel C; Becker G; Köpke J; Hentschel F; Schmidt M; Georgi M
Rofo; 1999 Apr; 170(4):371-7. PubMed ID: 10341796
[TBL] [Abstract][Full Text] [Related]
5. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
6. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
7. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla.
Gruber S; Frey R; Mlynárik V; Stadlbauer A; Heiden A; Kasper S; Kemp GJ; Moser E
Invest Radiol; 2003 Jul; 38(7):403-8. PubMed ID: 12821853
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
9. [1H-MR spectroscopy in anorexia nervosa: the characteristic differences between patients and healthy subjects].
Hentschel J; Möckel R; Schlemmer HP; Markus A; Göpel C; Gückel F; Köpke J; Georgi M; Schmidt MH
Rofo; 1999 Mar; 170(3):284-9. PubMed ID: 10230438
[TBL] [Abstract][Full Text] [Related]
10. Quantitative multivoxel proton spectroscopy of the brain in developmental delay.
Verbruggen KT; Maurits NM; Meiners LC; Brouwer OF; van Spronsen FJ; Sijens PE
J Magn Reson Imaging; 2009 Oct; 30(4):716-21. PubMed ID: 19787717
[TBL] [Abstract][Full Text] [Related]
11. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
12. Effects of short-term stress-like cortisol on cerebral metabolism: a proton magnetic resonance spectroscopy study at 3.0 T.
Scheel M; Ströhle A; Bruhn H
J Psychiatr Res; 2010 Jun; 44(8):521-6. PubMed ID: 20022344
[TBL] [Abstract][Full Text] [Related]
13. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
15. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study.
Raininko R; Mattsson P
Acta Radiol; 2010 Apr; 51(3):309-15. PubMed ID: 20170295
[TBL] [Abstract][Full Text] [Related]
16. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
17. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
[TBL] [Abstract][Full Text] [Related]
19. MR spectroscopy in monitoring the treatment of Wilson's disease patients.
Tarnacka B; Szeszkowski W; Golebiowski M; Czlonkowska A
Mov Disord; 2008 Aug; 23(11):1560-6. PubMed ID: 18546325
[TBL] [Abstract][Full Text] [Related]
20. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla.
Schubert F; Gallinat J; Seifert F; Rinneberg H
Neuroimage; 2004 Apr; 21(4):1762-71. PubMed ID: 15050596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
